- Home
- PULM vs COCH Comparison
PULM vs COCH Comparison
Compare PULM & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- COCH
- Stock Information
- Founded
- PULM 2003
- COCH 1995
- Country
- PULM United States
- COCH United States
- Employees
- PULM N/A
- COCH N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- COCH Blank Checks
- Sector
- PULM Health Care
- COCH Finance
- Exchange
- PULM Nasdaq
- COCH Nasdaq
- Market Cap
- PULM 18.3M
- COCH 20.4M
- IPO Year
- PULM N/A
- COCH N/A
- Fundamental
- Price
- PULM $4.84
- COCH $0.73
- Analyst Decision
- PULM
- COCH Strong Buy
- Analyst Count
- PULM 0
- COCH 1
- Target Price
- PULM N/A
- COCH $9.50
- AVG Volume (30 Days)
- PULM 4.3K
- COCH 405.2K
- Earning Date
- PULM 10-16-2025
- COCH 11-10-2025
- Dividend Yield
- PULM N/A
- COCH N/A
- EPS Growth
- PULM N/A
- COCH N/A
- EPS
- PULM N/A
- COCH N/A
- Revenue
- PULM $3,000.00
- COCH $208,000.00
- Revenue This Year
- PULM N/A
- COCH $3.66
- Revenue Next Year
- PULM $134.88
- COCH $31.19
- P/E Ratio
- PULM N/A
- COCH N/A
- Revenue Growth
- PULM N/A
- COCH N/A
- 52 Week Low
- PULM $4.26
- COCH $0.64
- 52 Week High
- PULM $10.40
- COCH $2.32
- Technical
- Relative Strength Index (RSI)
- PULM 47.70
- COCH 46.97
- Support Level
- PULM $4.26
- COCH $0.65
- Resistance Level
- PULM $4.85
- COCH $0.80
- Average True Range (ATR)
- PULM 0.24
- COCH 0.06
- MACD
- PULM -0.02
- COCH 0.01
- Stochastic Oscillator
- PULM 61.11
- COCH 62.94
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.